Research on Uterine Cervical Cancer in Korea: Current Status and Perspectives.
10.5124/jkma.2007.50.9.807
- Author:
Joo Hyun NAM
1
Author Information
1. Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Korea. jhnam@amc.seoul.kr
- Publication Type:Original Article
- Keywords:
Research;
Cervical cancer;
Current status;
Perspectives
- MeSH:
Female;
Humans;
Incidence;
Korea*;
Mass Screening;
Mortality;
Papanicolaou Test;
Uterine Cervical Neoplasms*
- From:Journal of the Korean Medical Association
2007;50(9):807-814
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
In Korea, cervical cancer is the fifth most common female cancer and the eighth most common cause of female cancer deaths. It is the most frequently diagnosed gynecologic cancer. Over the past decades, a marked reduction in the incidence and mortality of this malignancy has been documented. This has been largely attributed to widespread screening using papanicolaou smear, the early detection and treatment of preivasive lesions, and development of an effective treatment modality for invasive cervical cancer. The recently developed human papilomavirus vaccine is expected to further reduce the incidence and mortality of this malignancy markedly. Epidemiologic, biologic, and clinical research on cervical cancer is carried out worldwide to introduce human papillomavirus test and vaccine and to develop effective treatment for invasive cancer. At this point of time, the author reviewed the present status of research on cervical cancer and proposed future studies required to reduce the incidence and mortality of this malignancy in Korea.
